Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Dry Eye Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

100 recruiting trials for Dry Eye. Eligibility criteria explained in plain English.

TrialFinderData lists 100 Dry Eye clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 4 is the largest group at 33% (15 studies); the largest phase groups are Phase 4: 15, Phase 2: 11, Phase 1: 6, Phase 1 / Phase 2: 5.

Research is led by Beijing Tongren Hospital (3), Shanghai Changzheng Hospital (2), Lubris Bio Pty Ltd (2), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo (drug, 4 trials), followed by Vehicle Control, Transcutaneous Auricular Vagus Nerve Stimulation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Track Dry Eye trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT03921931

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT)...

Sponsor: Medical University of ViennaEnrolling: 351 location
RECRUITINGNCT07363824

A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.

This study aims to see if the amount of iron in tears is linked to how severe dry eye disease is. We hope this can lead to a new way to help diagnose and understand dry eye. This...

Sponsor: Shanghai Changzheng HospitalEnrolling: 521 location
RECRUITINGNCT06662162

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to...

Sponsor: i-Lumen Scientific AUS PTY LTDEnrolling: 10013 locations
RECRUITINGNCT06565091

Clinical Investigation for a Multifunction Ophthalmic Measurement Device

The purpose of this clinical investigation is to evaluate the clinical utility of a multifunctional measuring device for Ophtalmology. The results of this clinical investigation...

Sponsor: Essilor InternationalEnrolling: 3781 location
RECRUITINGPhase 2NCT07118241

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML...

rhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Australia to evaluate the safety and efficacy of topically-applied rhPRG4 in subjects with Sjögren's related...

Sponsor: Lubris Bio Pty LtdEnrolling: 806 locations
RECRUITINGNCT06830551

The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment

The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 101 location
RECRUITINGNCT04931160

B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome

The objectif is to study the diagnosis performance of the different classification criteria in reference to the gold standard consisting of the diagnosis made by expert doctors...

Sponsor: University Hospital, BrestEnrolling: 10001 location
RECRUITINGPhase 4NCT07243275

SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

This is a prospective, randomized, double-masked, multi-site clinical trial designed to compare the efficacy of SYSTANE® PRO (Alcon Laboratories, Inc.) to MIEBO™ (Bausch + Lomb)...

Sponsor: Indiana UniversityEnrolling: 2604 locations
RECRUITINGNCT06536075

Functional Analysis of Salivary Glands and Correlation With Sialoscintigraphy in Sjogren's Syndrome

Sjögren's syndrome is a complex autoimmune disorder. The investigators hypothesize that striated ductal cells may function as non-professional antigen-presenting cells in...

Sponsor: National Taiwan University HospitalEnrolling: 601 location
RECRUITINGPhase 4NCT07396441

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

The goal of this clinical trial is to evaluate the effects of stingless bee honey (Kelulut honey) in juvenile open-angle glaucoma patients. The study evaluates the effects on...

Sponsor: Universiti Sains MalaysiaEnrolling: 604 locations
RECRUITINGNCT07412860

Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and...

The goal of this clinical investigation plan is to evaluate the performance, tolerability, safety, and compliance of an ophthalmic solution containing an ancillary medicinal...

Sponsor: FB Vision S.p.AEnrolling: 742 locations
RECRUITINGPhase 2NCT06557460

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

This is a Phase IIb randomized, clinical trial designed to assess the safety and efficacy of unilateral implantation of the CPCB-RPE1 implant in subjects with geographic atrophy...

Sponsor: Regenerative Patch Technologies, LLCEnrolling: 245 locations
RECRUITINGPhase 1 / Phase 2NCT07298811

Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the...

Evaluate the efficacy and safety of ocular surface microbiota transplantation as an adjunctive therapy for dry eye, and explore its impact on the structure of the ocular surface...

Sponsor: Second Affiliated Hospital of Nanchang UniversityEnrolling: 401 location
RECRUITINGNCT07579130

Comparative Assessment of Lipid Layer Thickness Measurements

This study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement and consistency. It...

Sponsor: Indiana UniversityEnrolling: 501 location
RECRUITINGPhase 2NCT06794008

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

The objective of this study is to evaluate the efficacy and safety of BCMA/CD19 chimeric antigen receptor (CAR)-modified T cells in the treatment of autoimmune diseases.

Sponsor: Peking University People's HospitalEnrolling: 501 location
RECRUITINGNCT06984549

Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID)

This study aims to evaluate the diagnostic accuracy and grading consistency of a mobile phone-attached portable automatic ocular surface imaging device (PAOSID) for assessing dry...

Sponsor: Chen WeiEnrolling: 1501 location
RECRUITINGEarly Phase 1NCT06548607

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

This is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of CD19 or...

Sponsor: Nanjing Bioheng Biotech Co., Ltd.Enrolling: 201 location
RECRUITINGPhase 2NCT06780293

Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy of adding laser acupuncture at Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi...

Sponsor: Taipei Veterans General Hospital, TaiwanEnrolling: 1401 location
RECRUITINGPhase 3NCT07404865

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Sponsor: Vor BiopharmaEnrolling: 25020 locations
RECRUITINGPhase 2NCT04673643

Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease

Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We...

Sponsor: Beijing Tongren HospitalEnrolling: 1282 locations
RECRUITINGNCT04198740

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 3002 locations
RECRUITINGPhase 1 / Phase 2NCT07062523

Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT

Sjögren's syndrome (SS) is a chronic autoimmune disease primarily affecting the salivary and lacrimal glands, leading to symptoms of dryness. Assessing the inflammatory activity...

Sponsor: Peking Union Medical College HospitalEnrolling: 601 location
RECRUITINGNCT07571330

Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.

This study evaluates the therapeutic effect of upper punctal plug occlusion in patients with dry eye disease with previous lower punctal occlusion.

Sponsor: Universidad Autonoma de Nuevo LeonEnrolling: 361 location
RECRUITINGNCT06298890

The Pattern of Dry Eye Disease After Cataract Surgery

This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with...

Sponsor: Lithuanian University of Health SciencesEnrolling: 1001 location
RECRUITINGNCT06893913

Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients

insulin resistant psoriatic obese patients may complain problems of dryness of eye. Intermittent fasting may improve dryness of eye, obesity, insulin resistance, and psoriasis....

Sponsor: Cairo UniversityEnrolling: 401 location
RECRUITINGNCT04848870

Dental and Periodontal Status of Patients With Sjögren's Syndrome.

Sjögren's syndrome (SS) is a rare chronic systemic autoimmune disease characterized by destruction of the exocrine glands, including the salivary glands.The lack of saliva exposes...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1001 location
RECRUITINGNCT06596733

Vit-A-Vision® Clinical Investigation

Symptoms of ocular discomfort include dryness, burning, stinging, photophobia, foreign body sensation and contact lens intolerance. These symptoms may affect basic daily...

Sponsor: OmniVision GmbHEnrolling: 771 location
RECRUITINGNCT04946721

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

Evaluate and study the immunologic changes to the ocular surface in cancer patients.

Sponsor: University of Maryland, BaltimoreEnrolling: 1501 location
RECRUITINGPhase 3NCT06879782

Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease

This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of Lifitegrast Ophthalmic Solution.

Sponsor: Lunan Better Pharmaceutical Co., LTD.Enrolling: 8201 location
RECRUITINGNCT07295691

Autologous Serum Eye Drops in Dry Eye Syndrome

This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to...

Sponsor: The General Authority for Teaching Hospitals and InstitutesEnrolling: 701 location
RECRUITINGEarly Phase 1NCT07526350

MTS109 in Patients With Refractory Autoimmune Diseases

This is the first-in-human trial of MTS109 (mRNA-LNP). The goal of this clinical trial is to evaluate the safety, tolerability of intravenous injection of MTS109 in moderate to...

Sponsor: Shanghai Changzheng HospitalEnrolling: 151 location
RECRUITINGNCT07446582

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

The goal of this observational clinical study is to learn if DeepMSI AI detects age-related macular degeneration (AMD) biomarkers with sensitivity and specificity equivalent to...

Sponsor: AI-SpectralEnrolling: 10001 location
RECRUITINGPhase 4NCT06655441

The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

The purpose of this research study is to evaluate the effects of trehalose, an ingredient found in commercially available artificial tears, on the corneal barrier function. The...

Sponsor: Southern California College of Optometry at Marshall B. Ketchum UniversityEnrolling: 301 location
RECRUITINGNCT07144137

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

This is a non-interventional, observational study to provide insights into the short-term progression of GA secondary to AMD in participants aged ≥55 years. This is a...

Sponsor: Complement TherapeuticsEnrolling: 7512 locations
RECRUITINGNCT07173530

Low Level Light Therapy & Skin Pigmentation

The goal of this clinical trial is to determine if there is a difference in eyelid temperature after low-level light therapy (LLLT) in individuals with different amounts of skin...

Sponsor: University of HoustonEnrolling: 401 location
RECRUITINGNCT04402086

Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Sponsor: Yale UniversityEnrolling: 50001 location
RECRUITINGPhase 1NCT07236762

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 181 location
RECRUITINGNCT06454370

Histopathological Analysis Versus Full-field Optical Coherence Tomography of Minor Salivary Gland Biopsy in Suspect...

Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that mainly affects the exocrine glands leading to severe dryness of mucosal surfaces, principally in the mouth and...

Sponsor: Centre Hospitalier de MâconEnrolling: 301 location
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
RECRUITINGNCT05605314

Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye

Primary Sjögren's syndrome is a chronic autoimmune disease that primarily involves exocrine glands, most commonly manifested in dry eye, dry mouth, and in other systems of the...

Sponsor: Peking University Third HospitalEnrolling: 5001 location
RECRUITINGPhase 3NCT06903884

3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis

The aim of the study is to investigate whether patients with moderate-to-severe VKC and keratitis will benefit from the addition of Diquafosol ophthalmic solution in terms of...

Sponsor: The University of Hong KongEnrolling: 941 location
RECRUITINGNCT06976515

Study for Remote Investigation of Evaporative Dry Eye Disease

Dry eye disease is a common problem that can make your eyes feel uncomfortable and affect your vision, making daily tasks harder. Many past studies on dry eye treatments haven't...

Sponsor: University of California, San FranciscoEnrolling: 901 location
RECRUITINGNCT04796545

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related...

The objective of this study is to demonstrate the safety and effectiveness of the SING IMT (Smaller Incision New Generation Implantable Miniature Telescope) 3X implant in...

Sponsor: VisionCare, Inc.Enrolling: 7613 locations
RECRUITINGPhase 1NCT07041099

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

A phase 1b, open-label study of CLN-978 administered subcutaneously in patients with active, moderate to severe Sjogren's Disease.

Sponsor: Cullinan Therapeutics Inc.Enrolling: 3611 locations
RECRUITINGNCT07297849

Eyelid Closure in Keratometry

Cataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the...

Sponsor: Vienna Institute for Research in Ocular SurgeryEnrolling: 291 location
RECRUITINGPhase 4NCT06017362

Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

The goal of this clinical trial is to evaluate the preliminary efficacy of the use of insulin eye drops in the control of dry eye disease in patients with topical hypotensors,...

Sponsor: Barbara Burgos BlascoEnrolling: 1001 location
RECRUITINGPhase 2NCT07656688

Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease

Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients with moderate to...

Sponsor: Huons Co., Ltd.Enrolling: 1501 location
RECRUITINGNCT05927688

Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or...

Inflammatory rheumatic diseases affect 1% of the population. Treatment of such diseases should be based on disease activity, safety issues and other patient characteristics such...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 3521 location
RECRUITINGPhase 2 / Phase 3NCT07548632

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry...

Sponsor: OculisEnrolling: 16014 locations
RECRUITINGPhase 2NCT07118254

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML...

An 84-day, prospective, randomized (1:1) vehicle controlled, double-masked pre-market, crossover study. Subjects with moderate to severe oGVHD related Dry Eye Disease Each subject...

Sponsor: Lubris Bio Pty LtdEnrolling: 153 locations

Showing 50 of 100 trials.Search all Dry Eye trials

Frequently Asked Questions

There are currently 100 clinical trials for Dry Eye, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Dry Eye, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 5 Phase 3 trials for Dry Eye, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.